In major news released today, Cell Applications and Cyfuse Biomedical K.K. announced a collaboration to further progress with 3D printing of cells and tissues. The collaboration will partner Cell Applications’ primary cell bank with Cyfuse Biomedical’s innovative 3D bioprinter to create scaffold-free 3D tissue constructs.
This advanced tissue-engineering service will now be available to researchers in North America.
To learn more about the collaboration, read the company press release below.
New Scaffold-Free 3D Bioprinting Method Available to Researchers for First Time in North America
Cell Applications primary cells and Regenova 3D Bio Printer from Cyfuse Biomedical combine to print robust 3D tissue without introduction of extraneous scaffolding material
SAN DIEGO, Feb. 8, 2016 /PRNewswire/– Cell Applications, Inc. and Cyfuse Biomedical K.K. have announced that advanced tissue-engineering services are now available in North America using a groundbreaking new three-dimensional (3D) bioprinting approach called the “Kenzan Method.” Utilizing Cyfuse Biomedical’s Regenova® 3D Bio Printer, a state-of-the-art robotic system that fabricates 3D tissue from cells, Cell Applications has created a powerful pay-for-service bio-printing model that makes scaffold-free tissue available immediately to scientists in the U.S. and Canada for research use. [Read more…]